Following the withdrawal of US troops from Afghanistan in August 2021 and the Taliban’s rapid takeover, maternal and […]

Moderna CEO Bancel set for a soft landing as his golden parachute swells to $926M kdunleavy Fri, 03/11/2022 […]

Treatment demonstrated a good safety profile in the overall patient population during the 12-week induction phase

Fierce Pharma Asia—Legend CEO’s cell therapy ambitions; Indian pharmas’ awkward position; new Hutchmed CEO aliu Fri, 03/11/2022 – […]

BeiGene, Hutchmed, Zai Lab tagged for potential US delisting under SEC audit rules, with more Chinese biotechs likely […]

Amid inflation spike, execs at J&J, Bayer, GSK and more talk higher costs—and what it means for profits […]

Skoltech researchers and their colleagues from HSE University and York University have presented an extensive dataset of indices […]

Calculating a person’s risk of developing prostate cancer using results from two blood markers would improve the accuracy […]

Listen“Listen to the patient; he is telling you the diagnosis.” I should be surprised if this aphorism has […]

93% of people suspected by GPs to have cancer should be seen by a specialist within two weeks […]